Diethyl Ether → HCID 68660307, Verbindung

HRID 1773052

Reaktionsgleichung

Reaktionsgleichung von HRID 1773052
[CH2:1]([N:8]1[CH:12]=[CH:11][N:10]=[C:9]1[CH2:13][OH:14])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[CH3:15][CH2:16][O:17][CH2:18][CH3:19]>CC[N+](CC1C=CC=CC=1)(CC)CC.[Cl-].C1(C)C=CC=CC=1.[OH-].[Na+]>[CH2:1]([N:8]1[CH:12]=[CH:11][N:10]=[C:9]1[CH2:13][O:14][CH2:19][CH2:18][O:17][CH:16]=[CH2:15])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

Komponenten

6

Versuchsvorschrift

0.54 g of TEBAC (2.4×10−3 mol) and 5.6 g of CEVE (0.05 mol) are added to a solution of 1-benzyl-2-hydroxymethylimidazole (4.7 g, 0.024 mol.) in toluene (15 ml). A basic solution 20 N in NaOH (100 ml) is then added in the medium and the heterogeneous mixture is brought to 90° C. for 24 h with vigorous stirring. After cooling, the solution is diluted with 250 ml of decanted ether, then the organic phase is washed with water until pH=7 (10×100 ml). The organic phase is dried on Na2SO4, filtered, then evaporated under reduced pressure to yield 5.3 g (85%) of desired product. Given the satisfactory purity of the obtained product, no further purification is required.

Aufarbeitung

  1. temperatureAfter cooling
  2. washthe organic phase is washed with water until pH=7 (10×100 ml)
  3. customThe organic phase is dried on Na2SO4
  4. filtrationfiltered
  5. customevaporated under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-19ffd579d44d4a55829791c022dcd017
Quelldatensatz
uspto-grants-2016_02
Patentnummer
US09252446B2

Verknüpfte Notizen

Wird geladen…